title: [Pharmacotherapeutic choices for correction of disorders of primary hemostasis].
abstract: A defective primary haemostatic system is a relatively frequent disorder, due to the increasing use of aspirin and other non-steroid anti-inflammatory agents (NSAIDs) by the general population. Impaired primary haemostasis may result in enhanced perioperative bleeding. Administration of desmopressin is an effective pharmacotherapeutic intervention that will improve the process of primary haemostasis in many cases, with or without additional interventions in the clotting system.
authors.affiliation: Afd. Inwendige Geneeskunde, Academisch Medisch Centrum/Universiteit van Amsterdam.
authors.forename: M
authors.initials: M
authors.lastname: Levi
authors.forename: M M
authors.initials: MM
authors.lastname: Koopman
authors.forename: E
authors.initials: E
authors.lastname: Briët
mesh_terms: D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D020147:Coagulation Protein Disorders / Q000188:drug therapy*; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use*; D005260:Female; D006487:Hemostasis / Q000187:drug effects*; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D019990:Perioperative Care
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D006490:Hemostatics; D003894:Deamino Arginine Vasopressin